{"log_id": 6207794016928662427, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 2e-06, "average": 0.999362, "min": 0.991648}, "location": {"width": 866, "top": 162, "height": 30, "left": 114}, "words": "用伊马替尼治疗担心影响生育力的男性患者应咨询他们的医生,详见【药理毒理】"}, {"probability": {"variance": 0, "average": 0.99956, "min": 0.998872}, "location": {"width": 131, "top": 211, "height": 28, "left": 120}, "words": "【儿童用药】"}, {"probability": {"variance": 3.6e-05, "average": 0.997934, "min": 0.969715}, "location": {"width": 922, "top": 258, "height": 31, "left": 161}, "words": "3岁以上儿童使用本品请参见【用法用量】。主要来自国外儿童研究数据,中国儿童人群"}, {"probability": {"variance": 0, "average": 0.999352, "min": 0.99837}, "location": {"width": 269, "top": 307, "height": 28, "left": 112}, "words": "用药安全有效性数据有限"}, {"probability": {"variance": 5e-06, "average": 0.998879, "min": 0.991482}, "location": {"width": 292, "top": 354, "height": 29, "left": 162}, "words": "尚无3岁以下儿童用药经验"}, {"probability": {"variance": 0, "average": 0.999402, "min": 0.99837}, "location": {"width": 131, "top": 401, "height": 29, "left": 121}, "words": "【老年用药】"}, {"probability": {"variance": 1e-06, "average": 0.999415, "min": 0.995854}, "location": {"width": 796, "top": 451, "height": 31, "left": 164}, "words": "与年龄有关的肌酐清除率的降低对甲磺酸伊马替尼的药代动力学无明显影响"}, {"probability": {"variance": 4e-06, "average": 0.998903, "min": 0.990307}, "location": {"width": 921, "top": 497, "height": 35, "left": 161}, "words": "应用本品治疗的老年患者或有心脏疾病史的患者,应首先测左心室射血分数(LVEF),在"}, {"probability": {"variance": 2e-06, "average": 0.999254, "min": 0.992959}, "location": {"width": 846, "top": 546, "height": 31, "left": 112}, "words": "治疗期间,患者有明显的心衰症状,应全面检查,并根据临床症状进行相应治疗"}, {"probability": {"variance": 6e-06, "average": 0.998273, "min": 0.99263}, "location": {"width": 178, "top": 594, "height": 28, "left": 121}, "words": "【药物相互作用】"}, {"probability": {"variance": 1e-06, "average": 0.999421, "min": 0.996473}, "location": {"width": 344, "top": 640, "height": 29, "left": 112}, "words": "可改变伊马替尼血浆浓度的药物"}, {"probability": {"variance": 6.8e-05, "average": 0.996014, "min": 0.950067}, "location": {"width": 921, "top": 689, "height": 32, "left": 159}, "words": "CYP3A4抑制剂:健康受试者同时服用单剂酮康唑(CYP3A4抑制剂)后,伊马替尼的"}, {"probability": {"variance": 0.000107, "average": 0.996316, "min": 0.947264}, "location": {"width": 970, "top": 736, "height": 36, "left": 111}, "words": "药物暴露量显著增加(平均最高血浆浓度(Cmax)和伊马替尼曲线下面积(AUC)可分别增"}, {"probability": {"variance": 5.2e-05, "average": 0.996078, "min": 0.963526}, "location": {"width": 968, "top": 786, "height": 32, "left": 111}, "words": "加26%和40%)。尚无与其它CYP3A4抑制剂(如:伊曲康唑、红霉素和克拉霉素)同时服"}, {"probability": {"variance": 3e-06, "average": 0.997529, "min": 0.995159}, "location": {"width": 98, "top": 834, "height": 27, "left": 111}, "words": "用的经验"}, {"probability": {"variance": 0.003001, "average": 0.987513, "min": 0.642395}, "location": {"width": 917, "top": 881, "height": 33, "left": 162}, "words": "CYP3A4诱导剂:健康志愿者服用利福平后,伊马替尼的清除增加3.8倍(90%可信区间"}, {"probability": {"variance": 0.010254, "average": 0.953336, "min": 0.570424}, "location": {"width": 950, "top": 930, "height": 31, "left": 116}, "words": "=.5-4.3倍),但Cmax,AUC024)和AUC(o-8分别下降54%、68%和74%。在临床研究中发现"}, {"probability": {"variance": 2e-06, "average": 0.999128, "min": 0.993033}, "location": {"width": 968, "top": 977, "height": 32, "left": 111}, "words": "同时给予苯妥英药物后伊马替尼的血浆浓度降低,从而导致疗效减低。在服用酶诱导的抗癫"}, {"probability": {"variance": 0.00504, "average": 0.969926, "min": 0.730664}, "location": {"width": 968, "top": 1028, "height": 32, "left": 110}, "words": "痫药( enzyme- -inducing anti- epileptic drugs, EIAEDS)如卡马西平、奥卡西平、苯妥英、磷苯"}, {"probability": {"variance": 1.1e-05, "average": 0.998961, "min": 0.978972}, "location": {"width": 966, "top": 1074, "height": 32, "left": 111}, "words": "妥英、苯巴比妥及去氧苯比妥,同时接受本品治疗的恶性神经胶质瘤患者中亦观察到类似的"}, {"probability": {"variance": 0.007329, "average": 0.974562, "min": 0.566745}, "location": {"width": 968, "top": 1120, "height": 35, "left": 110}, "words": "结果。与不同时服用 EIAEDS相比,伊马替尼的AUC降至73%,其它OYP3A4诱导剂如地"}, {"probability": {"variance": 2.2e-05, "average": 0.997896, "min": 0.973732}, "location": {"width": 968, "top": 1170, "height": 32, "left": 111}, "words": "塞米松、卡他咪嗪、苯巴比妥等,可能有类似问题,因此应避免伊马替尼与CYP3A4诱导剂"}, {"probability": {"variance": 1.9e-05, "average": 0.99783, "min": 0.975799}, "location": {"width": 967, "top": 1217, "height": 34, "left": 110}, "words": "同时服用。在已发表的两项研究中,伊马替尼与含有 St John麦汁浸膏制剂合用时可导致本品"}, {"probability": {"variance": 0.000415, "average": 0.989938, "min": 0.923277}, "location": {"width": 242, "top": 1268, "height": 27, "left": 111}, "words": "的AUC下降30%~32%"}, {"probability": {"variance": 2e-06, "average": 0.999036, "min": 0.994043}, "location": {"width": 465, "top": 1314, "height": 31, "left": 109}, "words": "甲磺酸伊马替尼可使下列药物改变血浆浓度"}, {"probability": {"variance": 0.000433, "average": 0.991647, "min": 0.883903}, "location": {"width": 921, "top": 1362, "height": 32, "left": 157}, "words": "伊马替尼使辛伐他丁(CYP3A4底物)的平均Cmax和AUC分别增加2倍和3.5倍。应"}, {"probability": {"variance": 8.3e-05, "average": 0.99646, "min": 0.945607}, "location": {"width": 958, "top": 1408, "height": 35, "left": 109}, "words": "谨记伊马替尼可增加经CYP3A4代谢的其他药物(如苯二氮类、双氢吡啶、钙通道拮抗剂"}, {"probability": {"variance": 0.00712, "average": 0.980486, "min": 0.51882}, "location": {"width": 968, "top": 1458, "height": 31, "left": 110}, "words": "和其它HMG-CoA还原酶抑制剂等)的血浆浓度。因此当同时服用本药和治疗窗狭窄的"}, {"probability": {"variance": 8.8e-05, "average": 0.995776, "min": 0.955226}, "location": {"width": 505, "top": 1506, "height": 29, "left": 113}, "words": "CYP3A4底物(如环孢素、匹莫齐特)时应谨慎"}, {"probability": {"variance": 0.000287, "average": 0.981649, "min": 0.964695}, "location": {"width": 22, "top": 1609, "height": 22, "left": 585}, "words": "17"}], "language": 3}